Home › Compare › AOXG vs DGRO

AOXG vs DGRO: Dividend Comparison 2026

AOXG yields 50000.00% · DGRO yields 2.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AOXG wins by $4.789070889867552e+23M in total portfolio value
10 years
AOXG
AOXG
● Live price
50000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.789070889867552e+23M
Annual income
$477,030,307,353,597,400,000,000,000,000.00
Full AOXG calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.10%
Share price
$70.18
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$235.38
Full DGRO calculator →

Portfolio growth — AOXG vs DGRO

📍 AOXG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAOXGDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AOXG + DGRO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AOXG pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AOXG
Annual income on $10K today (after 15% tax)
$4,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$405,475,761,250,557,800,000,000,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$178.14/yr
After 10yr DRIP, annual income (after tax)
$200.07/yr
At 15% tax rate, AOXG beats the other by $405,475,761,250,557,800,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AOXG + DGRO for your $10,000?

AOXG: 50%DGRO: 50%
100% DGRO50/50100% AOXG
Portfolio after 10yr
$2.394535444933776e+23M
Annual income
$238,515,153,676,798,700,000,000,000,000.00/yr
Blended yield
99.61%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AOXG buys
0
DGRO buys
0
No recent congressional trades found for AOXG or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAOXGDGRO
Forward yield50000.00% ✓2.10%
Annual dividend / share$2.00 ✓$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.789070889867552e+23M$31.6K ✓
Annual income after 10y$477,030,307,353,597,400,000,000,000,000.00 ✓$235.38
Total dividends collected$4.7878388715795706e+23M ✓$2.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: AOXG vs DGRO ($10,000, DRIP)

YearAOXG PortfolioAOXG Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$5,010,700$5,000,000.00$11,290$209.57+$5.00M → AOXG
2$2,346,810,047$2,341,448,598.13$12,722$213.54+$2346.80M → AOXG
3$1,027,408,478,283$1,024,897,391,532.38$14,314$217.18+$1027408.46M → AOXG
4$420,435,006,832,721$419,335,679,760,958.80$16,080$220.53+$420435006.82M → AOXG
5$160,823,792,302,236,830$160,373,926,844,925,820.00$18,040$223.59+$160823792302.22M → AOXG
6$57,504,652,079,586,796,000$57,332,570,621,823,390,000.00$20,215$226.40+$57504652079586.78M → AOXG
7$19,220,418,850,978,506,000,000$19,158,888,873,253,350,000,000.00$22,627$228.96+$19220418850978508.00M → AOXG
8$6,005,321,287,350,842,000,000,000$5,984,755,439,180,295,000,000,000.00$25,302$231.31+$6005321287350842368.00M → AOXG
9$1,754,001,526,315,678,800,000,000,000$1,747,575,832,538,213,200,000,000,000.00$28,268$233.44+$1.7540015263156787e+21M → AOXG
10$478,907,088,986,755,200,000,000,000,000$477,030,307,353,597,400,000,000,000,000.00$31,557$235.38+$4.789070889867552e+23M → AOXG

AOXG vs DGRO: Complete Analysis 2026

AOXG — Stock

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.

Full AOXG Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this AOXG vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AOXG vs SCHDAOXG vs JEPIAOXG vs OAOXG vs KOAOXG vs MAINAOXG vs VIGAOXG vs NOBLAOXG vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.